By GINA KOLATA, nytimes.comDoctors who treat patients with heart failure have long been puzzled by a peculiar observation. Many black patients seem to do just as well if they take a mainstay of therapy, a class of drugs called beta blockers, as if they do not. It is almost as if they were immune to the drugs.
Now researchers at Washington University and the University of Maryland have discovered why: these nonresponsive patients have a slightly altered version of a gene that muscles use to control responses to nerve signals. People with this altered gene are making what amounts to their own version of beta blockers all the time. As many as 40 percent of blacks and 2 percent of whites have the gene variant, the researchers report.
The findings, heart failure specialists say, mean that people with the altered gene might be spared taking what may be, for them, a useless therapy. And since patients with heart failure typically take multiple drugs, which can interact and cause side effects like fatigue, getting rid of a drug that is not helping can be a huge benefit.
This is the first time anyone has found such a gene effect, said Dr. Stephen Liggett, a heart failure and genetics researcher at the University of Maryland and one of the first authors of the study.
http://www.nytimes.com/2008/04/29/health/research/29heart.html">Complete article